Kevin J. Fitzgerald

Executive Vice President, Chief Scientific Officer

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Alnylam Pharmaceuticals, Inc. (ALNY)	Executive Vice President, Chief Scientific Officer	$586,600	—	$725,000	$722,900	$616,550	$22,150	$2,673,200
2023	Alnylam Pharmaceuticals, Inc. (ALNY)	Executive Vice President, Chief Scientific Officer	$539,600	—	$950,050	$948,360	$329,180	$17,960	$2,785,150
2022	Alnylam Pharmaceuticals, Inc. (ALNY)	Executive Vice President, Chief Scientific Officer	$493,700	—	—	$1,604,260	$330,630	$17,090	$2,445,680

No earnings-call appearances recorded yet.